Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Zevia PBC (ZVIA) Stock Forecast & Price Prediction United States | NYSE | Consumer Defensive | Beverages - Non-Alcoholic
$2.61
+0.02 (0.77%)Did ZVIA Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Zevia is one of their latest high-conviction picks.
Based on our analysis of 8 Wall Street analysts, ZVIA has a bullish consensus with a median price target of $5.50 (ranging from $2.90 to $6.00). The overall analyst rating is N/A (N/A/10). Currently trading at $2.61, the median forecast implies a 110.7% upside. This outlook is supported by 4 Buy, 2 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Sarang Vora at Telsey Advisory Group, projecting a 129.9% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for ZVIA.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 6, 2025 | Telsey Advisory Group | Sarang Vora | Outperform | Maintains | $6.00 |
| Oct 29, 2025 | Telsey Advisory Group | Sarang Vora | Outperform | Maintains | $6.00 |
| Aug 14, 2025 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $6.00 |
| Aug 12, 2025 | Morgan Stanley | Dara Mohsenian | Equal-Weight | Maintains | $2.70 |
| Aug 7, 2025 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $5.00 |
| Aug 7, 2025 | BMO Capital | Andrew Strelzik | Outperform | Maintains | $6.00 |
| Aug 4, 2025 | Telsey Advisory Group | Dana Telsey | Outperform | Upgrade | $5.00 |
| May 8, 2025 | Telsey Advisory Group | Dana Telsey | Market Perform | Maintains | $3.00 |
| May 5, 2025 | Telsey Advisory Group | Dana Telsey | Market Perform | Maintains | $3.00 |
| Feb 27, 2025 | Telsey Advisory Group | Dana Telsey | Market Perform | Maintains | $3.00 |
| Jan 14, 2025 | Goldman Sachs | Bonnie Herzog | Neutral | Maintains | $3.75 |
| Jan 14, 2025 | Telsey Advisory Group | Dana Telsey | Market Perform | Maintains | $4.00 |
| Nov 7, 2024 | Telsey Advisory Group | Dana Telsey | Market Perform | Maintains | $2.00 |
| Nov 4, 2024 | Telsey Advisory Group | Dana Telsey | Market Perform | Maintains | $2.00 |
| May 9, 2024 | Telsey Advisory Group | Dana Telsey | Market Perform | Maintains | $2.00 |
| May 9, 2024 | Wells Fargo | Chris Carey | Equal-Weight | Maintains | $1.00 |
| May 9, 2024 | Goldman Sachs | Bonnie Herzog | Neutral | Maintains | $1.25 |
| Feb 28, 2024 | Morgan Stanley | Dara Mohsenian | Equal-Weight | Maintains | $2.00 |
| Feb 21, 2024 | Telsey Advisory Group | Dana Telsey | Market Perform | Reiterates | $4.00 |
| Nov 8, 2023 | Morgan Stanley | Dara Mohsenian | Equal-Weight | Maintains | $3.00 |
The following stocks are similar to Zevia based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Zevia PBC has a market capitalization of $175.70M with a P/E ratio of -7.7x. The company generates $162.85M in trailing twelve-month revenue with a -8.8% profit margin.
Revenue growth is +12.3% quarter-over-quarter, while maintaining an operating margin of -7.0% and return on equity of -39.4%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Produces zero-calorie, naturally sweetened beverages.
Zevia PBC generates revenue by selling a variety of zero-calorie beverages, including sodas, energy drinks, mixers, and teas, primarily through retail channels. The company targets health-conscious consumers looking for natural and clean-label alternatives to traditional sugary drinks, leveraging the popularity of stevia as a natural sweetener.
Based in Los Angeles, Zevia is positioned within the growing non-alcoholic beverage market, which is increasingly focusing on health and wellness. The company's commitment to non-GMO, vegan, and gluten-free products strengthens its appeal to environmentally and health-conscious consumers, allowing it to expand its reach in supermarkets and health food stores across North America.
Consumer Defensive
Beverages - Non-Alcoholic
108
Ms. Amy E. Taylor
United States
2021
KO's steady gains, strong innovation and margin expansion fuel momentum, but its premium valuation keeps investors weighing their next move.
Zevia PBC (NYSE:ZVIA) will present at the Stephens Annual Investment Conference on November 18, 2025, in Nashville, featuring CEO Amy Taylor and CFO Girish Satya.
Zevia's participation in the Stephens Annual Investment Conference highlights its engagement with investors, potentially influencing stock performance and market perception.
Zevia PBC (ZVIA) will hold its Q3 2025 Earnings Call on November 5, 2025, at 4:30 PM EST, featuring CEO Amy Taylor and CFO Girish Satya among participants.
Zevia's Q3 earnings call reveals financial performance, strategic insights, and management's outlook, crucial for assessing growth potential and investment decisions.
Zevia PBC (NYSE: ZVIA) reported Q3 2025 net sales of $40.8M, up 12.3%. Gross profit margin at 45.6% decreased by 3.5%. The company posted a net loss of $2.8M with a loss per share of $0.0.
Zevia's Q3 sales growth indicates strong demand, but declining gross margins and a net loss raise concerns about profitability and cost management, impacting investor confidence.
Zevia (ZVIA) reported a quarterly loss of $0.04 per share, better than the Zacks Consensus Estimate of $0.06, matching its loss from the same quarter last year.
Zevia's smaller-than-expected quarterly loss may signal improved operational efficiency, potentially boosting investor confidence and impacting future stock performance.
Zevia PBC (NYSE:ZVIA) will release its Q3 2025 financial results on November 5, 2025, after market close, followed by a conference call at 4:30 PM ET.
Zevia's upcoming financial results announcement and conference call may impact investor sentiment and stock performance, providing insights into the company's growth and market position.
Zevia PBC focuses on zero-sugar beverages, showing improving gross margins, stabilizing sales, and narrowing losses. It has a debt-free balance sheet and attractive valuation compared to peers.
Zevia's focus on zero-sugar products aligns with consumer trends, while improving financials and attractive valuation suggest growth potential amid competitive pressures.
Based on our analysis of 8 Wall Street analysts, Zevia PBC (ZVIA) has a median price target of $5.50. The highest price target is $6.00 and the lowest is $2.90.
According to current analyst ratings, ZVIA has 4 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $2.61. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict ZVIA stock could reach $5.50 in the next 12 months. This represents a 110.7% increase from the current price of $2.61. Please note that this is a projection by Wall Street analysts and not a guarantee.
Zevia PBC generates revenue by selling a variety of zero-calorie beverages, including sodas, energy drinks, mixers, and teas, primarily through retail channels. The company targets health-conscious consumers looking for natural and clean-label alternatives to traditional sugary drinks, leveraging the popularity of stevia as a natural sweetener.
The highest price target for ZVIA is $6.00 from Sarang Vora at Telsey Advisory Group, which represents a 129.9% increase from the current price of $2.61.
The lowest price target for ZVIA is $2.90 from at , which represents a 11.1% increase from the current price of $2.61.
The overall analyst consensus for ZVIA is bullish. Out of 8 Wall Street analysts, 4 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $5.50.
Stock price projections, including those for Zevia PBC, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.